Sitemap
En
Invest in TEDA
Strategic Opportunities
Industrial Competitiveness
Soft Advantages
Current Location: Home > Invest in TEDA > Industrial Competitiveness > Medicine & Health
Industrial Competitiveness
Medicine & Health    

Overview

·China’s No.1 Production Base of Insulin and Enzymes

·China’s No.1 Production Base of Instant Food and Drinking Water

With 50.76 billion yuan yielded from its medicine & health in 2020, TEDA is home to accumulatively over 800 such companies.


After 30 years of development, five major industrial clusters have been formed in the fields of biopharmaceutical, medical instruments, pharmaceutical R&D outsourcing, food and drink, and big health.

Biopharmaceuticals

Medical Devices


CROs

Food & Bevearges


Big Health



Medicine & Health


Overview


·China’s No.1 Production Base of Insulin and Enzymes

·China’s No.1 Production Base of Instant Food and Drinking Water


With 50.76 billion yuan yielded from its medicine & health in 2020, TEDA is home to accumulatively over 800 such companies.



After 30 years of development, five major industrial clusters have been formed in the fields of biopharmaceutical, medical instruments, pharmaceutical R&D outsourcing, food and drink, and big health.

Biopharmaceuticals

Medical Devices


CROs

Food & Bevearges


Big Health


Website Identification Code: 1201160062

Are you sure you want to leave this page?